Synuclein Biomarker Assays
Parkinson's disease and synucleinopathies
Commercial/DevelopmentActive
Key Facts
Indication
Parkinson's disease and synucleinopathies
Phase
Commercial/Development
Status
Active
Company
About ADx NeuroSciences
ADx NeuroSciences, founded in 2008 and based in Ghent, Belgium, is a specialized diagnostics company developing innovative biomarker assays for neurodegenerative disorders like Alzheimer's, Parkinson's, and Motor Neuron Diseases. Its core capabilities include proprietary antibody generation and the development of robust, fit-for-purpose immunoassays tailored for drug development and clinical research. Operating as a Fujirebio company, ADx serves pharmaceutical clients and technology providers, aiming to improve clinical trial success and patient outcomes through precise biomarker measurement.
View full company profile